Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

被引：119

作者：

Lyke, Kirsten E. ^{[1
]}

Atmar, Robert L. ^{[2
]}

Islas, Clara Dominguez ^{[3
]}

Posavad, Christine M. ^{[3
,4
]}

Szydlo, Daniel ^{[5
]}

Chourdhury, Rahul Paul ^{[5
]}

Deming, Meagan E. ^{[1
]}

Eaton, Amanda ^{[6
]}

Jackson, Lisa A. ^{[7
]}

Branche, Angela R. ^{[8
]}

Sahly, Hana M. El ^{[2
]}

Rostad, Christina A. ^{[9
]}

Martin, Judith M. ^{[10
]}

Johnston, Christine ^{[3
,4
,11
]}

Rupp, Richard E. ^{[12
]}

Mulligan, Mark J. ^{[13
]}

Brady, Rebecca C. ^{[14
]}

Frenck, Robert W., Jr. ^{[14
]}

Backer, Martin ^{[15
]}

Kottkamp, Angelica C. ^{[13
]}

Babu, Tara M. ^{[11
]}

Rajakumar, Kumaravel ^{[10
]}

Edupuganti, Srilatha ^{[16
,17
]}

Dobrzynski, David ^{[8
]}

Coler, Rhea N. ^{[18
,19
]}

Archer, Janet I. ^{[20
]}

Crandon, Sonja ^{[21
]}

Zemanek, Jillian A. ^{[5
]}

Brown, Elizabeth R. ^{[3
]}

Neuzil, Kathleen M. ^{[1
]}

Stephens, David S. ^{[16
]}

Post, Diane J. ^{[21
]}

Nayak, Seema U. ^{[21
]}

Suthar, Mehul S. ^{[22
]}

Roberts, Paul C. ^{[21
]}

Beigel, John H. ^{[21
]}

Montefiori, David C. ^{[23
]}

DMID Std Grp

机构：

[1] Univ Maryland Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA

[2] Baylor Coll Med, Dept Med & Mol Virol & Microbiol, Houston, TX 77030 USA

[3] Univ Washington, Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA USA

[4] Univ Washington, Fred Hutchinson Canc Res Ctr, Dept Lab Med & Pathol, Seattle, WA USA

[5] Univ Washington, Stat Ctr HIV AIDS Res & Prevent SCHARP, Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[6] Duke Univ Med Ctr, Dept Surg, Durham, NC USA

[7] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA

[8] Univ Rochester, Dept Med, Div Infect Dis, Rochester, NY USA

[9] Emory Univ Sch Med & Childrens Healthcare Atlanta, Ctr Childhood Infect & Vaccines, Dept Pediat, Atlanta, GA USA

[10] Univ Pittsburgh Sch Med, Dept Pediat, Pittsburgh, PA USA

[11] Univ Washington, Dept Med, Seattle, WA USA

[12] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX USA

[13] NYU Langone Vaccine Ctr, NYU Grossman Sch Med, Dept Med, Div Infect Dis & Immunol, New York, NY USA

[14] Univ Cincinnati Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH USA

[15] NYU Langone Hosp, Mineola, NY USA

[16] Emory Univ Sch Med, Dept Med, Atlanta, GA USA

[17] Hope Clin Emory Vaccine Ctr, Atlanta, GA USA

[18] Univ Washington Sch Med, Seattle Childrens Res Inst, Seattle, WA USA

[19] Univ Washington Sch Med, Dept Pediat, Seattle, WA USA

[20] FHI360, Durham, NC 27701 USA

[21] Natl Inst Allergy & Infect Dis, NIH, Div Microbiol & Infect Dis, Bethesda, MD USA

[22] Emory Univ, Atlanta, GA USA

[23] Duke Univ Med Ctr, Duke Human Vaccine Inst, Durham, NC 27710 USA

来源：

CELL REPORTS MEDICINE | 2022年 / 3卷 / 07期

基金：

美国国家卫生研究院;

关键词：

BA.2.12.1; BA.4/BA.5; booster; COVID-19; mRNA vaccine; neutralizing antibody; Omicron variant; recombinant adenovirus vaccine; SARS-CoV-2; sublineage;

D O I：

10.1016/j.xcrm.2022.100679

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibits reduced susceptibility to vaccine-induced neutralizing antibodies, requiring a boost to generate protective immunity. We assess the magnitude and short-term durability of neutralizing antibodies after homologous and heterologous boosting with mRNA and Ad26.COV2.S vaccines. All prime-boost combinations substantially increase the neutralization titers to Omicron, although the boosted titers decline rapidly within 2 months from the peak response compared with boosted titers against the prototypic D614G variant. Boosted Omicron neutralization titers are substantially higher for homologous mRNA vaccine boosting, and for heterologous mRNA and Ad26.COV2.S vaccine boosting, compared with homologous Ad26.COV2.S boosting. Homologous mRNA vaccine boosting generates nearly equivalent neutralizing activity against Omicron sublineages BA.1, BA.2, and BA.3 but modestly reduced neutralizing activity against BA.2.12.1 and BA.4/BA.5 compared with BA.1. These results have implications for boosting requirements to protect against Omicron and future variants of SARS-CoV-2.

引用

页数：13

共 50 条

[31] Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine
Arunachalam, Prabhu S.
Feng, Yupeng
Ashraf, Usama
Hu, Mengyun
Walls, Alexandra C.
Edara, Venkata Viswanadh
Zarnitsyna, Veronika, I
Aye, Pyone Pyone
Golden, Nadia
Miranda, Marcos C.
Green, Kristyn W. M.
Threeton, Breanna M.
Maness, Nicholas J.
Beddingfield, Brandon J.
Bohm, Rudolf P.
Scheuermann, Sarah E.
Goff, Kelly
Dufour, Jason
Russell-Lodrigue, Kasi
Kepl, Elizabeth
Fiala, Brooke
Wrenn, Samuel
Ravichandran, Rashmi
Ellis, Daniel
Carter, Lauren
Rogers, Kenneth
Shirreff, Lisa M.
Ferrell, Douglas E.
Adhikary, Nihar R. Deb
Fontenot, Jane
Hammond, Holly L.
Frieman, Matthew
Grifoni, Alba
Sette, Alessandro
O'Hagan, Derek T.
Van der Most, Robbert
Rappuoli, Rino
Villinger, Francois
Kleanthous, Harry
Rappaport, Jay
Suthar, Mehul S.
Veesler, David
Wang, Taia T.
King, Neil P.
Pulendran, Bali
SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (658)
[32] Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant
Wanbo Tai
Benjie Chai
Shengyong Feng
Xinyu Zhuang
Jun Ma
Mujia Pang
Lin Pan
Zi Yang
Mingyao Tian
Gong Cheng
Signal Transduction and Targeted Therapy, 7
[33] Bioinformatics approach for the construction of multiple epitope vaccine against omicron variant of SARS-CoV-2
Zaib, Sumera
Akram, Fatima
Liaqat, Syed Talha
Altaf, Muhammad Zain
Khan, Imtiaz
Dera, Ayed A.
Uddin, Jalal
Khan, Ajmal
Al-Harrasi, Ahmed
SCIENTIFIC REPORTS, 2022, 12 (01)
[34] SARS-CoV-2 Omicron variant: Immune escape and vaccine development
Ao, Danyi
Lan, Tianxia
He, Xuemei
Liu, Jian
Chen, Li
Baptista-Hon, Daniel T.
Zhang, Kang
Wei, Xiawei
MEDCOMM, 2022, 3 (01):
[35] The Contagious Nature of SARS-CoV-2 Omicron Variant and Vaccine Efficacy
Khan, Shahab Ahmad
Ahmad, Ijaz
Khan, Wajid
Khan, Hayat
Akbar, Sadiq
Akbar, Sadiq
ADVANCEMENTS IN LIFE SCIENCES, 2022, 9 (04): : 429 - 436
[36] Identification of vaccine candidate against Omicron variant of SARS-CoV-2 using immunoinformatic approaches
Ruchika Aasim
C. R. Sharma
Anoop Patil
Kalicharan Kumar
In Silico Pharmacology, 10 (1)
[37] Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant
Tai, Wanbo
Chai, Benjie
Feng, Shengyong
Zhuang, Xinyu
Ma, Jun
Pang, Mujia
Pan, Lin
Yang, Zi
Tian, Mingyao
Cheng, Gong
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
[38] Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
Park, Jun-Gyu
Oladunni, Fatai S.
Chiem, Kevin
Ye, Chengjin
Pipenbrink, Michael
Moran, Thomas
Walter, Mark R.
Kobie, James
Martinez-Sobrido, Luis
JOURNAL OF VIROLOGICAL METHODS, 2021, 287
[39] Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display
Tanaka, Shiho
Olson, C. Anders
Barnes, Christopher O.
Higashide, Wendy
Gonzalez, Marcos
Taft, Justin
Richardson, Ashley
Martin-Fernandez, Marta
Bogunovic, Dusan
Gnanapragasam, Priyanthi N. P.
Bjorkman, Pamela J.
Spilman, Patricia
Niazi, Kayvan
Rabizadeh, Shahrooz
Soon-Shiong, Patrick
CELL REPORTS, 2022, 38 (06):
[40] Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Elisabetta Cameroni
John E. Bowen
Laura E. Rosen
Christian Saliba
Samantha K. Zepeda
Katja Culap
Dora Pinto
Laura A. VanBlargan
Anna De Marco
Julia di Iulio
Fabrizia Zatta
Hannah Kaiser
Julia Noack
Nisar Farhat
Nadine Czudnochowski
Colin Havenar-Daughton
Kaitlin R. Sprouse
Josh R. Dillen
Abigail E. Powell
Alex Chen
Cyrus Maher
Li Yin
David Sun
Leah Soriaga
Jessica Bassi
Chiara Silacci-Fregni
Claes Gustafsson
Nicholas M. Franko
Jenni Logue
Najeeha Talat Iqbal
Ignacio Mazzitelli
Jorge Geffner
Renata Grifantini
Helen Chu
Andrea Gori
Agostino Riva
Olivier Giannini
Alessandro Ceschi
Paolo Ferrari
Pietro E. Cippà
Alessandra Franzetti-Pellanda
Christian Garzoni
Peter J. Halfmann
Yoshihiro Kawaoka
Christy Hebner
Lisa A. Purcell
Luca Piccoli
Matteo Samuele Pizzuto
Alexandra C. Walls
Michael S. Diamond
Nature, 2022, 602 : 664 - 670

← 1 2 3 4 5 →